HomeCompareETBI vs NOBL

ETBI vs NOBL: Dividend Comparison 2026

ETBI yields 200000.00% · NOBL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ETBI wins by $4.911780474428384e+29M in total portfolio value
10 years
ETBI
ETBI
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full ETBI calculator →
NOBL
NOBL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NOBL calculator →

Portfolio growth — ETBI vs NOBL

📍 ETBI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodETBINOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ETBI + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ETBI pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ETBI
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, ETBI beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ETBI + NOBL for your $10,000?

ETBI: 50%NOBL: 50%
100% NOBL50/50100% ETBI
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ETBI buys
0
NOBL buys
0
No recent congressional trades found for ETBI or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricETBINOBL
Forward yield200000.00%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$4.911780474428384e+29M$28.0K
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00$899.19
Total dividends collected$4.911464459982279e+29M$6.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ETBI vs NOBL ($10,000, DRIP)

YearETBI PortfolioETBI Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,120$420.00+$20.00METBI
2$37,424,589,019$37,403,177,570.09$12,357$458.31+$37424.58METBI
3$65,416,215,188,220$65,376,170,877,969.18$13,721$499.76+$65416215.17METBI
4$106,868,230,495,008,900$106,798,235,144,757,520.00$15,227$544.58+$106868230494.99METBI
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$16,885$593.02+$163172871735896.84METBI
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$18,713$645.34+$232854599801468864.00METBI
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$20,724$701.81+$310570858137017057280.00METBI
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$22,938$762.73+$3.871481543016132e+23METBI
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$25,372$828.41+$4.510617497632811e+26METBI
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$28,047$899.19+$4.911780474428384e+29METBI

ETBI vs NOBL: Complete Analysis 2026

ETBIStock

EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.

Full ETBI Calculator →

NOBLETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →
📬

Get this ETBI vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ETBI vs SCHDETBI vs JEPIETBI vs OETBI vs KOETBI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.